Status:
COMPLETED
The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Conditions:
Cancer
Inflammation
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the study is to determine whether positron emission tomography using the new imaging agent 18F-FAC can be used for imaging cancer and/or inflammation.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- \> 18 years of age
- women of childbearing potential will undergo a pregnancy test free of charge
- patients with cancer or autoimmune diseases or healthy subjects
Exclusion
Key Trial Info
Start Date :
November 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01180907
Start Date
November 1 2007
Last Update
July 31 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLA
Los Angeles, California, United States, 90095